2686-0529 Screening compound: N-(2-benzoyl-1-benzofuran-3-yl)-2-phenylacetamide

2686-0529 Screening compound: N-(2-benzoyl-1-benzofuran-3-yl)-2-phenylacetamide
2686-0529 Screening compound: N-(2-benzoyl-1-benzofuran-3-yl)-2-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2686-0529
N-(2-benzoyl-1-benzofuran-3-yl)-2-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2686-0529

Molecular Formula

C23H17NO3 (C23 H17 NO3)

Compound Name

N-(2-benzoyl-1-benzofuran-3-yl)-2-phenylacetamide

IUPAC name

N-(2-benzoyl-1-benzofuran-3-yl)-2-phenylacetamide

SMILES

O=C(Cc1ccccc1)Nc1c(C(c2ccccc2)=O)oc2c1cccc2

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

355.39

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.468

Distribution Coefficient, logD

4.463

Water Solubility, LogSw

-4.53

Polar Surface Area

43.714

Acid Dissociation Constant (pKa)

9.36

Base Dissociation Constant (pKb)

-1.53

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

4.30

2686-0529 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Antiviral Annotated Library (21441 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS targets activity set (6557 compounds)

Human GPCR Annotated Library (5539 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with 2686-0529 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2686-0529?
Check Price and Availability of 2686-0529, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2686-0529 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2686-0529
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2686-0529
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2686-0529 available by request